Navigation Links
High-Dose Flu Vaccine May Better Protect the Elderly: Study
Date:8/13/2014

By
HealthDay Reporter

WEDNESDAY, Aug. 13, 2014 (HealthDay News) -- The high-dose flu shot protects seniors better than the standard dose does, a new study finds.

About one in four cases of flu in older patients vaccinated with the standard dose could be prevented if the high-dose vaccine were used instead, the researchers reported.

"The study demonstrated a 24 percent reduction in influenza illness among the participants who received the high-dose vaccine compared to those who received the standard dose," said study co-author Dr. David Greenberg, vice president for scientific and medical affairs and chief medical officer for Sanofi Pasteur U.S., the maker of the Fluzone High-Dose vaccine and funder of the trial.

This protection is over and above the protection one gets from the standard flu shot, Greenberg noted.

He pointed out that the added protection is essential for older people. "People 65 and older account for about 60 percent of hospitalizations due to flu and about 90 percent of deaths that are flu-related," he said.

Older people tend to have weaker immune systems and don't respond as well to the standard flu shot, Greenberg explained. The high-dose vaccine was designed to address these weaknesses, he said.

Fluzone High-Dose vaccine is an inactivated influenza vaccine containing four times the vaccine found in the standard dose, Greenberg explained.

Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City, said he recommends the high-dose vaccine for his older patients. "People 65 and older do not process vaccines as well as younger people," he explained.

"Protection from the flu vaccine is not 100 percent -- it's about 60 percent effective," Horovitz said. "But if you can increase it by 15 or 20 percent, that's something."

Dr. Ambreen Khalil, an infectious diseases specialist at Staten Island University Hospital in New York City, said she is also inclined to give the high-dose vaccine to her older patients.

"We did have a lot of vaccine failure this year. A lot of patients got sick even after taking the vaccine, so if we can do something better for these patients then I would consider doing that for my patients," Khalil said.

Fluzone High-Dose is approved for people 65 and older, but is not recommended for people who have had a severe reaction to the flu vaccine in the past, according to the U.S. Centers for Disease Control and Prevention.

The CDC does not specifically recommend Fluzone High-Dose for all seniors. Rather, the agency recommends "flu vaccination as the first and most important step in protecting against flu viruses."

The report was published Aug. 14 in the New England Journal of Medicine.

For the study, researchers randomly assigned nearly 32,000 men and women aged 65 and older to receive either the high-dose flu shot or a regular dose.

Greenberg and his colleagues found that people given the high-dose shot produced more antibodies against the flu than those given the standard dose.

Greenberg also noted that the high-dose vaccine may help prevent hospitalizations, pneumonia, heart and lung problems, doctor visits and medication use.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on the flu.

SOURCES: David Greenberg, M.D., vice president, scientific and medical affairs, and chief medical officer, Sanofi Pasteur U.S., Swiftwater, Penn.; Len Horovitz, M.D., pulmonary specialist, Lenox Hill Hospital, New York City; Ambreen Khalil, M.D., infectious diseases specialist, Staten Island University Hospital, New York City; Aug. 14, 2014, New England Journal of Medicine


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. High-dose fluticasone effective against eosinophilic esophagitis
2. Predicting outcome for high-dose IL-2 therapy in cancer patients
3. Reducing Unnecessary and High-dose Pediatric CT Scans Could Cut Associated Cancers by 62 Percent
4. High-Dose Statins Linked to Acute Kidney Damage
5. High-dose Vorinostat effective at treating relapsed lymphomas
6. Controlling spine metastases with tumor separation surgery and high-dose stereotactic radiosurgery
7. Microvax cancer vaccine first in human clinical trial in Singapore
8. HPV vaccine could close the gap on Indigenous health
9. MicroVAX Cancer Vaccine First in Human Clinical Trial in Singapore
10. Ebola Vaccine Trials Set to Begin in September
11. A vaccine alternative protects mice against malaria
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
High-Dose Flu Vaccine May Better Protect the Elderly: Study 
(Date:6/27/2016)... ... June 27, 2016 , ... ... professionals, announced today its affiliation with Tennessee Counseling Association. This new ... network of the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... ... legally blind and certified personal trainer is helping to develop a weight loss fitness plan ... fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 The vast ... an outpatient dialysis facility.  Treatments are usually 3 times ... hours per visit, including travel time, equipment preparation and ... patient, but especially grueling for patients who are elderly ... a skilled nursing and rehabilitation centers for some duration ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
(Date:6/23/2016)... -- The National Pharmaceutical Council (NPC) today announced that ... organization as its newest member.  ... and chief scientific officer, Mallinckrodt Pharmaceuticals, will serve ... of Directors. ... in support of our efforts to conduct research ...
Breaking Medicine Technology: